FDA Orange Book · active-ingredient family
Neomycin sulfate; prednisolone sodium phosphate
Neomycin sulfate; prednisolone sodium phosphate is approved in 1 FDA application, with therapeutic-equivalence codes, listed patents, and marketing exclusivity from the FDA Orange Book.
Reference-listed drug:NEO-HYDELTRASOL · NDA 050378
1
Brand (NDA)
0
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · ointment
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| NEO-HYDELTRASOL | MERCK | NDA 050378 | — | Approved Prior to Jan 1, 1982 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Neomycin sulfate; prednisolone sodium phosphate — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
